Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1
CA 2470685 A1 · Owner: Repair, Inc · Inventors: Burgess, Wilson H.; Drohan, William N.; Maciag, Thomas
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to novel degradation resistant FGF-1 and methods for , producing and using the same. More specifically the invention relates to , identification of a thrombin degradation resistant FGF-1 and a nucleic acid , encoding the same. The thrombin degradation resistant FGF-1 can elicit responses that are otherwise typically impeded by degradation of FGF-1 by thrombin. Thrombin degradation resistant FGF-1 is an important molecule for effecting an FGF-1 response that would be otherwise inhibited by thrombin. Thus the present invention provides a powerful therapeutic for diseases or disorders wherein an FGF-1 response can mediate a reduction in the frequency or intensity of …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 11, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 11, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 11, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.